This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Melvin C. Godwin, MD

JAMA. 1965;194(1):88-89.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

EXTRAPULMONARY infections caused by unclassified acid-fast mycobacteria of Runyon group I photochromogenic type without accompanying pulmonary disease have been rarely reported. It is generally accepted that two of the Runyon groups' of atypical mycobacteria are capable of producing progressive disease. One is group I, photochromogenic Mycobacterium kansasii. This group is characterized by colonial pigmentation following purposeful exposure of the culture to light. These microorganisms often possess a natural resistance to the major antituberculous drugs in low concentration. Experience with in vitro drugsensitivity testing has taught the need for initially higher doses of drugs, particularly isoniazid (INH). It is with this well-defined group of mycobacteria that the present case is identified.

Group III, nonchromogenic Battey strain of atypical mycobacteria, produces indolent disease that is difficult, if at all possible, to reproduce in laboratory animals. It possesses natural resistance to low concentrations of antituberculous drugs. It is easily differentiated from M tuberculosis . . . [Full Text PDF of this Article]

Author Affiliations
From the Department of Pathology, St. Mary of Nazareth Hospital, Chicago.

Footnotes
Reprint requests to 1120 N Leavitt St, Chicago, 60622.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?